[ Price : $8.95]
Effective 11/30, FDAs Office of Internal Affairs loses its authority to investigate agency employees for alleged criminal miscondu...[ Price : $8.95]
FDA approves an Eli Lilly supplemental NDA for Cymbalta and its use for maintenance treatment of major depressive disorder in adul...[ Price : $8.95]
FDA approves six-months pediatric exclusivity for AstraZenecas Arimidex.[ Price : $8.95]
Pipex Pharmaceuticals files an NDA for Coprexa, indicated for treating Wilsons disease.[ Price : $8.95]
FDA accepts for review a UCB NDA for Vimpat (lacosamide), indicated for treating diabetic neuropathic pain.[ Price : $8.95]
Sen. Herb Kohl asks FDA for detailed information on Genentechs decision to limit availability of its Avastin to certain compoundin...[ Price : $8.95]
Government Accountability Project executive director Mark Cohen says more states should drop the learned intermediary doctrine and...[ Price : $8.95]
The UKs health products regulator says its increased review of new drug launches and ads has led to fewer complaints and fewer cor...